BioSig Launches PURE EP™ Software Version 6 with ACCUVIZ™ Module
Westport, CT, Sept. 22, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (BioSig or the Company), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP System, today announced the release of PURE EP Software Version 6 with ACCUVIZ Module.
- Westport, CT, Sept. 22, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (BioSig or the Company), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP System, today announced the release of PURE EP Software Version 6 with ACCUVIZ Module.
- Built around three highly differentiating features, PURE EP Software Version 6 with ACCUVIZ Module introduces the proprietary High Frequency Algorithm (HFA), a novel feature that identifies the key frequency components of cardiac data that can be difficult to identify within the traditional waveform presentation.
- PURE EP Software Version 6 with ACCUVIZ Module is the first to be designed and launched by the Companys new commercial and operations team and represents the most advanced iteration of the Companys digital signal processing technology.
- PURE EP Software Version 6 with ACCUVIZ Module acquires raw intracardiac signals in their digital form to provide a new level of efficiency and automaticity.